Jean-Luc Tétard
Directeur Général chez Stragen Chemical SA
Profil
Jean-Luc Tétard is currently the Chairman & Managing Director at Stragen Chemical SA, a Non-Executive Director at ChemGenex Pharmaceuticals, Inc., a Director at Stragen International NV, and the Managing Director at Stragen Pharma SA. Previously, he worked as a Director in the Chemical Division at Sanofi and as a Non-Executive Director at ChemGenex Pharmaceuticals Pty Ltd.
from 2008 to 2011.
Postes actifs de Jean-Luc Tétard
| Sociétés | Poste | Début |
|---|---|---|
Stragen Chemical SA
 Stragen Chemical SA Chemicals: Major DiversifiedProcess Industries Stragen Chemical SA researches, develops and sells bulk API's and neutral ingredients. The company was founded in 1990 and is headquartered in Geneva, Switzerland. | Directeur Général | 06/04/2011 |
Stragen Pharma SA
 Stragen Pharma SA Pharmaceuticals: MajorHealth Technology Stragen Pharma SA is a Swiss pharmaceutical company that has been committed to the development of advanced generics since 1990. The company is based in Plan-les-Ouates, Switzerland, and has subsidiaries in Germany. The company focuses on innovation for health solutions and consistently operates under the latest quality standards to deliver Swiss tailor-made solutions for public health. Stragen offers a range of consumer health products with unique, natural formulas made from scientifically selected active ingredients. The company was founded in 1990, and the CEO is Jean-Luc Tétard. | Directeur Général | 07/04/2011 |
| Stragen International NV | Directeur/Membre du Conseil | 14/04/2011 |
ChemGenex Pharmaceuticals, Inc.
 ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 03/06/2011 |
Anciens postes connus de Jean-Luc Tétard
| Sociétés | Poste | Fin |
|---|---|---|
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia. | Directeur/Membre du Conseil | 07/06/2011 |
| SANOFI | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANOFI | Health Technology |
| Entreprise privées | 5 |
|---|---|
ChemGenex Pharmaceuticals Pty Ltd.
ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia. | Health Technology |
Stragen Chemical SA
Stragen Chemical SA Chemicals: Major DiversifiedProcess Industries Stragen Chemical SA researches, develops and sells bulk API's and neutral ingredients. The company was founded in 1990 and is headquartered in Geneva, Switzerland. | Process Industries |
Stragen Pharma SA
Stragen Pharma SA Pharmaceuticals: MajorHealth Technology Stragen Pharma SA is a Swiss pharmaceutical company that has been committed to the development of advanced generics since 1990. The company is based in Plan-les-Ouates, Switzerland, and has subsidiaries in Germany. The company focuses on innovation for health solutions and consistently operates under the latest quality standards to deliver Swiss tailor-made solutions for public health. Stragen offers a range of consumer health products with unique, natural formulas made from scientifically selected active ingredients. The company was founded in 1990, and the CEO is Jean-Luc Tétard. | Health Technology |
| Stragen International NV | |
ChemGenex Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA. | Health Technology |
